株探米国株
英語
エドガーで原本を確認する
6-K 1 bbucq120256kcoverpage.htm 6-K Document

QuickLinks -- Click here to rapidly navigate through this document


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
____________________________________________________________________________

FORM 6-K
____________________________________________________________________________


REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of May 2025
Commission File Number: 001-41313
____________________________________________________________________________

BROOKFIELD BUSINESS CORPORATION
(Translation of registrant's name into English)
____________________________________________________________________________


250 Vesey Street, 15th Floor
New York, NY 10281
(Address of principal executive office)
____________________________________________________________________________


Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ý                                Form 40-F o
Exhibit 99.1 included in this Form 6-K is incorporated by reference into Brookfield Business Corporation's registration statement on Form F-3 (File No: 333-273180).



EXHIBIT LIST



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  BROOKFIELD BUSINESS CORPORATION
/s/ A.J. Silber
Date: May 6, 2025 By:   Name: A.J. Silber
Title: Managing Director

QuickLinks




EX-99.1 2 bbucq12025ex991.htm EX-99.1 Document




UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF

BROOKFIELD BUSINESS CORPORATION

As at March 31, 2025 and December 31, 2024 and for the
three months ended March 31, 2025 and 2024
1


INDEX TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS OF BROOKFIELD BUSINESS CORPORATION

Unaudited Interim Condensed Consolidated Statements of Financial Position
Unaudited Interim Condensed Consolidated Statements of Operating Results
Unaudited Interim Condensed Consolidated Statements of Comprehensive Income (Loss)
Unaudited Interim Condensed Consolidated Statements of Changes in Equity
Unaudited Interim Condensed Consolidated Statements of Cash Flow
Notes to Unaudited Interim Condensed Consolidated Financial Statements
2


BROOKFIELD BUSINESS CORPORATION
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS
OF FINANCIAL POSITION
(US$ MILLIONS) Notes March 31, 2025 December 31, 2024
Assets
Current Assets    
Cash and cash equivalents 3 $ 968  $ 1,008 
Financial assets 4 151  167 
Accounts and other receivable, net 6 1,460  1,337 
Inventory, net 7 59  52 
Other assets 8 369  371 
3,007  2,935 
Non-Current Assets
Financial assets 4 173  186 
Accounts and other receivable, net 6 1,937  1,892 
Other assets 8 272  256 
Property, plant and equipment 9 2,479  2,480 
Deferred income tax assets 206  197 
Intangible assets 10 6,031  5,966 
Equity accounted investments 12 201  198 
Goodwill 11 4,993  4,988 
$ 19,299  $ 19,098 
Liabilities and Equity    
Current Liabilities    
Accounts payable and other 13 $ 3,070  $ 2,990 
Non-recourse borrowings in subsidiaries of the company 15 146  111 
Exchangeable and class B shares 5 1,682  1,709 
4,898  4,810 
Non-Current Liabilities
Accounts payable and other 13 2,301  2,286 
Non-recourse borrowings in subsidiaries of the company 15 8,565  8,379 
Deferred income tax liabilities 951  988 
$ 16,715  $ 16,463 
Equity    
Brookfield Business Partners 19 $ (78) $ (59)
Non-controlling interests 2,662  2,694 
2,584  2,635 
$ 19,299  $ 19,098 

The accompanying notes are an integral part of the unaudited interim condensed consolidated financial statements.
3


BROOKFIELD BUSINESS CORPORATION
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS
OF OPERATING RESULTS
  Three Months Ended
March 31,
(US$ MILLIONS) Notes 2025 2024
Revenues 18 $ 1,966  $ 1,865 
Direct operating costs 17 (1,789) (1,652)
General and administrative expenses (75) (64)
Interest income (expense), net (219) (210)
Equity accounted income (loss) 12
Impairment reversal (expense), net —  (2)
Remeasurement of exchangeable and class B shares 5 (7) (111)
Other income (expense), net (34) (11)
Income (loss) before income tax (155) (184)
Income tax (expense) recovery
Current (23) (44)
Deferred 43  54 
Net income (loss) $ (135) $ (174)
Attributable to:  
Brookfield Business Partners (1)
$ (58) $ (150)
Non-controlling interests (77) (24)
$ (135) $ (174)
____________________________________
(1)Earnings per share have not been presented in the financial statements, as the underlying shares do not constitute “ordinary shares” under IAS 33, Earnings per Share (“IAS 33”). See Note 2(c) for further details.

The accompanying notes are an integral part of the unaudited interim condensed consolidated financial statements.
4


BROOKFIELD BUSINESS CORPORATION
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS
OF COMPREHENSIVE INCOME (LOSS)
    Three Months Ended
March 31,
(US$ MILLIONS) Notes 2025 2024
Net income (loss)   $ (135) $ (174)
Other comprehensive income (loss):  
Items that may be reclassified subsequently to profit or loss:  
Foreign currency translation   61  (81)
Net investment and cash flow hedges 3 (42) 59 
Taxes on the above items   (8)
Reclassification to profit or loss —  (17)
Total other comprehensive income (loss) 26  (47)
Comprehensive income (loss)   $ (109) $ (221)
Attributable to:  
Brookfield Business Partners   $ (52) $ (172)
Non-controlling interests   (57) (49)
  $ (109) $ (221)

The accompanying notes are an integral part of the unaudited interim condensed consolidated financial statements.
5


BROOKFIELD BUSINESS CORPORATION
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(US$ MILLIONS) Capital Retained earnings Ownership changes
Accumulated other
comprehensive income (loss) (1)
Brookfield Business Partners Non-controlling interests Total
equity
Balance as at January 1, 2025 $ 737  $ (247) $ (127) $ (422) $ (59) $ 2,694  $ 2,635 
Net income (loss) —  (58) —  —  (58) (77) (135)
Other comprehensive income (loss) —  —  —  20  26 
Total comprehensive income (loss) —  (58) —  (52) (57) (109)
Contributions 33  —  —  —  33  25  58 
Balance as at March 31, 2025 $ 770  $ (305) $ (127) $ (416) $ (78) $ 2,662  $ 2,584 
Balance as at January 1, 2024 $ 737  $ 637  $ (129) $ (365) $ 880  $ 3,880  $ 4,760 
Net income (loss) —  (150) —  —  (150) (24) (174)
Other comprehensive income (loss) —  —  —  (22) (22) (25) (47)
Total comprehensive income (loss) —  (150) —  (22) (172) (49) (221)
Contributions —  —  —  —  —  25  25 
Distributions and capital paid —  —  —  —  —  (22) (22)
Ownership changes and other —  11  —  14  —  14 
Balance as at March 31, 2024 $ 737  $ 498  $ (126) $ (387) $ 722  $ 3,834  $ 4,556 
____________________________________
(1)See Note 16 for additional information.

The accompanying notes are an integral part of the unaudited interim condensed consolidated financial statements.
6


BROOKFIELD BUSINESS CORPORATION
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
    Three Months Ended
March 31,
(US$ MILLIONS) Notes 2025 2024
Operating Activities      
Net income (loss) $ (135) $ (174)
Adjusted for the following items:  
Equity accounted earnings, net of distributions 12
Impairment expense (reversal), net — 
Depreciation and amortization expense 17 196  196 
Provisions and other items   36  (29)
Deferred income tax expense (recovery)   (43) (54)
Remeasurement of exchangeable and class B shares 5 111 
Changes in non-cash working capital, net 22 (112) (109)
Cash from (used in) operating activities   (50) (53)
Financing Activities      
Proceeds from non-recourse borrowings in subsidiaries of the company 89  352 
Repayment of non-recourse borrowings in subsidiaries of the company (47) (507)
Proceeds from other financing 16 
Repayment of other financing (26) (33)
Lease liability repayment (18) (17)
Capital provided by others who have interests in operating subsidiaries 57  13 
Repurchases of exchangeable shares 19 (33) — 
Distributions to exchangeable shareholders 5 (4) (5)
Proceeds received from loan with Brookfield Business Partners 49  320 
Repayment and issuance of loan with Brookfield Business Partners (1) — 
Distributions and capital paid to others who have interests in operating subsidiaries —  (15)
Cash from (used in) financing activities   71  124 
Investing Activities      
Acquisitions      
Property, plant and equipment and intangible assets (60) (76)
Equity accounted investments (10) — 
Financial assets and other (1) — 
Dispositions  
Property, plant and equipment and intangible assets
Financial assets and other — 
Net settlement of derivative assets and liabilities (10) (3)
Restricted cash and deposits   (11) (1)
Cash from (used in) investing activities   (90) (77)
Cash and cash equivalents      
Change during the period   (69) (6)
Impact of foreign exchange   29  (23)
Balance, beginning of year   1,008  772 
Balance, end of period   $ 968  $ 743 
Supplemental cash flow information is presented in Note 22.

The accompanying notes are an integral part of the unaudited interim condensed consolidated financial statements.
7

NOTES TO UNAUDITED INTERIM CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS

As at March 31, 2025 and December 31, 2024 and
for the three months ended March 31, 2025 and 2024

NOTE 1. ORGANIZATION AND DESCRIPTION OF THE COMPANY
(a)Brookfield Business Corporation
Brookfield Business Corporation together with its subsidiaries (the “company”) is an owner and operator of services and industrials operations on a global basis (the “businesses”). The company was formed as a corporation established under the Business Corporations Act (British Columbia) on June 21, 2021 and is a subsidiary of Brookfield Business Partners L.P. (NYSE: BBU; TSX: BBU.UN) (the “partnership”, or collectively with its subsidiaries, excluding the company, “Brookfield Business Partners”). Brookfield Business Partners, the company and respective subsidiaries are referred to collectively as the “group”. Brookfield Corporation (“Brookfield Corporation” or together with its controlled subsidiaries, excluding the group, “Brookfield”) is the ultimate parent of the company and the group. “Brookfield Holders” refers to Brookfield, Brookfield Wealth Solutions Ltd. and their related parties. Brookfield Business Partners holds all the issued and outstanding class B shares and class C shares of the company as at March 31, 2025. The registered head office of the company is 250 Vesey Street, New York, NY 10281, United States. The class A exchangeable subordinate voting shares (each, an “exchangeable share”) of the company are listed on the New York Stock Exchange (“NYSE”) and the Toronto Stock Exchange (“TSX”) under the symbol “BBUC”. The exchangeable shares are structured with the intention of being economically equivalent to the non-voting limited partnership units (“LP Units”) of the partnership. Given the economic equivalence, the market price of the exchangeable shares will be significantly impacted by the market price of the LP Units and the combined business performance of the company and Brookfield Business Partners as a whole.
NOTE 2. MATERIAL ACCOUNTING POLICY INFORMATION
(a)Basis of presentation
The unaudited interim condensed consolidated financial statements of the company have been prepared in accordance with IAS 34, Interim Financial Reporting (“IAS 34”), as issued by the International Accounting Standards Board (“IASB”) and using the accounting policies the company applied in its annual consolidated financial statements as at and for the year ended December 31, 2024. The accounting policies the company applied in its annual consolidated financial statements as at and for the year ended December 31, 2024 are disclosed in Note 2 of such consolidated financial statements, with which reference should be made in reading these unaudited interim condensed consolidated financial statements. All defined terms are also described in the annual consolidated financial statements. The unaudited interim condensed consolidated financial statements are prepared on a going concern basis and have been presented in U.S. dollars rounded to the nearest million unless otherwise indicated.
The unaudited interim condensed consolidated financial statements were approved by the Board of Directors and authorized for issue on May 6, 2025.
(b)Critical accounting judgments and measurement uncertainty
The preparation of financial statements in accordance with IAS 34 requires management to make critical judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period that are not readily apparent from other sources. The critical accounting estimates and judgments have been set out in Note 2 to the company’s annual consolidated financial statements as at and for the year ended December 31, 2024. These estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. There have been no significant changes to the method of determining critical accounting estimates and judgments relative to those described in the annual consolidated financial statements as at and for the year ended December 31, 2024.
8

NOTES TO UNAUDITED INTERIM CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS

As at March 31, 2025 and December 31, 2024 and
for the three months ended March 31, 2025 and 2024
(i)Global minimum top-up tax
The company operates in countries, including Canada, which have enacted new legislation to implement the global minimum top-up tax, effective from January 1, 2024. The company has applied a temporary mandatory relief from recognizing and disclosing deferred taxes in connection with the global minimum top-up tax and will account for it as a current tax when it is incurred. There is no material current tax impact for the three months ended March 31, 2025. The global minimum top-up tax is not anticipated to have a material impact on the financial position of the company.
(ii)Going concern
In assessing whether the going concern assumption is appropriate and whether there are material uncertainties that cast significant doubt on the company’s ability to continue as a going concern, management has made certain estimates and assumptions about future cash flows. These judgments considered various forward-looking factors, such as forecasted cash flows, access to financing and liquidity reserves, planned capital expenditures and debt repayment obligations. Management has also made specific estimates and judgments regarding future expected cash flows in assessing the going concern assumption at its healthcare services operation, considering currently ongoing strategic initiatives that include negotiations with lenders and landlords to amend debt and rent arrangements, negotiations with private health insurers to amend hospital funding agreements, deferral of uncommitted expenditures, and anticipated benefits from cost-saving measures. The assumptions underlying this assessment are based on actual operating results and the most relevant available information about the future, including the company’s strategic initiatives and business plans and may be affected by market conditions, regulatory developments, and macroeconomic risks.
(c)Earnings per Share
The company’s basic and diluted earnings per share have not been presented in the unaudited interim condensed consolidated financial statements. As outlined in Note 5, exchangeable shares and class B shares are classified as financial liabilities, while class C shares are classified as financial liabilities but presented as equity instruments given the narrow scope presentation exceptions existing in IAS 32, Financial Instruments: Presentation (“IAS 32”). As each share classification represents a financial liability, they do not constitute ordinary shares. Refer to the aforementioned note for further details.
(d)Future changes in accounting policies
(i)Amendments to IFRS 9, Financial Instruments (“IFRS 9”) and IFRS 7, Financial Instruments: Disclosures (“IFRS 7”) - Classification and Measurement of Financial Instruments
In May 2024, the IASB issued amendments which clarify the requirements for the timing of recognition and derecognition of financial liabilities settled through an electronic cash transfer system, add further guidance for assessing the contractual cash flow characteristics of financial assets with contingent feature, and add new or amended disclosures relating to investments in equity instruments designated at FVOCI and financial instruments with contingent features. The amendments to IFRS 9 and IFRS 7 apply to annual reporting periods beginning on or after January 1, 2026, with early adoption permitted. The company is currently assessing the impact of these amendments.
(ii)IFRS 18, Presentation and Disclosure of Financial Statements (“IFRS 18”)
In April 2024, the IASB issued IFRS 18 to replace IAS 1 Presentation of Financial Statements (“IAS 1”). IFRS 18 is effective for periods beginning on or after January 1, 2027, with early adoption permitted. IFRS 18 aims to improve financial reporting by requiring additional defined subtotals in the statement of profit or loss, requiring disclosures about management-defined performance measures, and adding new principles for the aggregation and disaggregation of items. The company is currently assessing the impact of these amendments.
There are currently no other future changes to IFRS Accounting Standards with expected material impacts on the company.
9

NOTES TO UNAUDITED INTERIM CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS

As at March 31, 2025 and December 31, 2024 and
for the three months ended March 31, 2025 and 2024
NOTE 3. FAIR VALUE OF FINANCIAL INSTRUMENTS
The following table provides the details of financial instruments and their associated financial instrument classifications as at March 31, 2025:
(US$ MILLIONS)
MEASUREMENT BASIS FVTPL FVOCI Amortized cost Total
Financial assets        
Cash and cash equivalents $ —  $ —  $ 968  $ 968 
Accounts and other receivable, net (current and non-current) —  —  3,397  3,397 
Financial assets (current and non-current) (1)
11  132  181  324 
Total $ 11  $ 132  $ 4,546  $ 4,689 
Financial liabilities        
Accounts payable and other (current and non-current) (1) (2)
$ —  $ 41  $ 3,780  $ 3,821 
Non-recourse borrowings in subsidiaries of the company (current and non-current) —  —  8,711  8,711 
Exchangeable and class B shares (3)
—  —  1,682  1,682 
Total $ —  $ 41  $ 14,173  $ 14,214 
____________________________________
(1)FVOCI includes derivative assets and liabilities designated in hedge accounting relationships. Refer to Hedging Activities in Note 3(a) below.
(2)Includes derivative liabilities and excludes liabilities associated with assets held for sale, provisions, decommissioning liabilities, deferred revenue, work in progress, post-employment benefits and other liabilities of $1,550 million.
(3)Class C shares are also classified as financial liabilities due to their cash redemption feature, however, these shares meet certain qualifying criteria and are therefore presented as equity instruments in accordance with IAS 32. See Note 19 for additional information.
Included in cash and cash equivalents as at March 31, 2025 is $204 million of cash (December 31, 2024: $340 million) and $764 million of cash equivalents (December 31, 2024: $668 million).
The following table provides the details of financial instruments and their associated financial instrument classifications as at December 31, 2024:
(US$ MILLIONS)
MEASUREMENT BASIS FVTPL FVOCI Amortized cost Total
Financial assets        
Cash and cash equivalents $ —  $ —  $ 1,008  $ 1,008 
Accounts and other receivable, net (current and non-current) —  —  3,229  3,229 
Financial assets (current and non-current) (1)
11  184  158  353 
Total $ 11  $ 184  $ 4,395  $ 4,590 
Financial liabilities        
Accounts payable and other (current and non-current) (1) (2)
$ —  $ 55  $ 3,641  $ 3,696 
Non-recourse borrowings in subsidiaries of the company (current and non-current) —  —  8,490  8,490 
Exchangeable and class B shares (3)
—  —  1,709  1,709 
Total $ —  $ 55  $ 13,840  $ 13,895 
____________________________________
(1)FVOCI includes derivative assets and liabilities designated in hedge accounting relationships. Refer to Hedging Activities in Note 3(a) below.
(2)Includes derivative liabilities and excludes liabilities associated with assets held for sale, provisions, decommissioning liabilities, deferred revenue, work in progress, post-employment benefits and other liabilities of $1,580 million.
(3)Class C shares are also classified as financial liabilities due to their cash redemption feature, however, these shares meet certain qualifying criteria and are therefore presented as equity instruments in accordance with IAS 32. See Note 19 for additional information.
10

NOTES TO UNAUDITED INTERIM CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS

As at March 31, 2025 and December 31, 2024 and
for the three months ended March 31, 2025 and 2024
(a)Hedging activities
Derivative instruments not designated in a hedging relationship are classified as FVTPL, with changes in fair value recognized in the unaudited interim condensed consolidated statements of operating results.
Net investment hedges
The company uses foreign exchange derivative contracts to manage foreign currency exposures arising from net investments in foreign operations. For the three month period ended March 31, 2025, a pre-tax net loss of $22 million (March 31, 2024: pre-tax net gain of $10 million), was recorded in other comprehensive income for the effective portion of hedges of net investments in foreign operations. As at March 31, 2025, there was a derivative asset balance of $81 million (December 31, 2024: $104 million) and derivative liability balance of $24 million (December 31, 2024: $36 million) relating to derivative contracts designated as net investment hedges.
Cash flow hedges
The company uses foreign exchange contracts and option contracts to hedge highly probable future transactions and interest rate contracts to hedge the cash flows on its floating rate borrowings. For the three month period ended March 31, 2025, a pre-tax net loss of $20 million (March 31, 2024: pre-tax net gain of $49 million) was recorded in other comprehensive income for the effective portion of cash flow hedges. As at March 31, 2025, there was an unrealized derivative asset balance of $51 million (December 31, 2024: $80 million) and a derivative liability balance of $17 million (December 31, 2024: $19 million) relating to the derivative contracts designated as cash flow hedges.
(b)Fair value hierarchical levels – financial instruments
The following table categorizes financial assets and liabilities, which are carried at fair value, based upon the level of input as at March 31, 2025 and December 31, 2024:
March 31, 2025 December 31, 2024
(US$ MILLIONS) Level 1 Level 2 Level 1 Level 2
Financial assets
Derivative assets —  132  —  184 
Other financial assets 11  —  11  — 
$ 11  $ 132  $ 11  $ 184 
Financial liabilities
Derivative liabilities $ —  $ 41  $ —  $ 55 
Other financial liabilities —  —  —  — 
$ —  $ 41  $ —  $ 55 
There were no financial instruments with significant Level 3 inputs as at March 31, 2025 and December 31, 2024.
There were no transfers between levels during the three months ended March 31, 2025.
11

NOTES TO UNAUDITED INTERIM CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS

As at March 31, 2025 and December 31, 2024 and
for the three months ended March 31, 2025 and 2024
NOTE 4. FINANCIAL ASSETS
(US$ MILLIONS) March 31, 2025 December 31, 2024
Current    
Restricted cash 67  61 
Derivative assets 84  106 
Total current $ 151  $ 167 
Non-current    
Restricted cash 37  22 
Derivative assets 48  78 
Loans and notes receivable 77  75 
Other financial assets 11  11 
Total non-current $ 173  $ 186 
NOTE 5. EXCHANGEABLE SHARES, CLASS B SHARES AND CLASS C SHARES
The exchangeable shares and the class B shares are classified as liabilities due to their exchangeable and cash redemption features. Upon issuance, the exchangeable shares and the class B shares were recognized at their fair values. Subsequent to initial recognition, the exchangeable shares and the class B shares are recognized at amortized cost and remeasured to reflect changes in the contractual cash flows associated with the shares. These contractual cash flows are based on the price of one LP Unit.
As at March 31, 2025, Brookfield Holders owned approximately 66% of the issued and outstanding exchangeable shares. The Brookfield Holders have agreed that all decisions to be made with respect to the exchangeable shares will be made jointly among the Brookfield Holders.
During the three months ended March 31, 2025, 154 exchangeable shares were exchanged into LP Units (March 31, 2024: 1). As at March 31, 2025, the exchangeable shares and the class B shares were remeasured to reflect the closing price of one LP Unit, which was valued at $23.46 per unit. Remeasurement gains or losses associated with the exchangeable shares and class B shares are recorded in remeasurement of exchangeable and class B shares in the unaudited interim condensed consolidated statements of operating results. During the three months ended March 31, 2025, $4 million of dividends (March 31, 2024: $5 million of dividends) were declared on the outstanding exchangeable shares of the company and included in interest income (expense), net in the unaudited interim condensed consolidated statements of operating results.
The following table provides a continuity schedule of outstanding exchangeable shares, and the class B shares, along with the carrying value of the corresponding liability and remeasurement gains and losses:
Exchangeable shares outstanding
(Shares)
Class B shares outstanding
(Shares)
Exchangeable shares and class B shares
(US$ Millions)
Balance as at January 1, 2025 72,954,446  $ 1,709 
Repurchased and canceled (1,260,225) —  (34)
Shares exchanged to LP Units (154) —  — 
Remeasurement (gains) losses —  — 
Balance as at March 31, 2025 71,694,067  $ 1,682 
Similar to the exchangeable shares and class B shares, the class C shares are classified as liabilities due to their cash redemption feature. However, the class C shares, the most subordinated class of all the company’s classes of common shares, meet certain qualifying criteria and are presented as equity instruments given the narrow scope presentation exceptions existing in IAS 32. Refer to Note 19 for further details related to class C shares.
12

NOTES TO UNAUDITED INTERIM CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS

As at March 31, 2025 and December 31, 2024 and
for the three months ended March 31, 2025 and 2024
NOTE 6. ACCOUNTS AND OTHER RECEIVABLE, NET
(US$ MILLIONS) March 31, 2025 December 31, 2024
Current, net $ 1,460  $ 1,337 
Non-current, net
Accounts receivable 90  100 
Retainer on customer contract 55  55 
Billing rights 652  597 
Loan receivable from Brookfield Business Partners (1)
1,140  1,140 
Total non-current, net $ 1,937  $ 1,892 
Total $ 3,397  $ 3,229 
____________________________________
(1)See Note 20 for additional information.
Non-current billing rights primarily represent unbilled rights from the company’s water and wastewater operation in Brazil from revenues earned from the construction of public concession contracts classified as financial assets, which are recognized when there is an unconditional right to receive cash or other financial assets from the concession authority for the construction services.
The company’s construction operation has a retention balance, which comprises amounts that have been earned but held back until the satisfaction of certain conditions specified in the contract. The retention balance included in the current accounts and other receivable, net as at March 31, 2025 was $60 million (December 31, 2024: $120 million).
NOTE 7. INVENTORY, NET
(US$ MILLIONS) March 31, 2025 December 31, 2024
Current
Raw materials and consumables $ 42  $ 41 
Finished goods and other 17  11 
Carrying amount of inventories $ 59  $ 52 
NOTE 8. OTHER ASSETS
(US$ MILLIONS) March 31, 2025 December 31, 2024
Current    
Work in progress (1)
$ 137  $ 138 
Prepayments and other assets 223  222 
Assets held for sale 11 
Total current $ 369  $ 371 
Non-current    
Prepayments and other assets $ 272  $ 256 
Total non-current $ 272  $ 256 
____________________________________
(1)See Note 14 for additional information.
13

NOTES TO UNAUDITED INTERIM CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS

As at March 31, 2025 and December 31, 2024 and
for the three months ended March 31, 2025 and 2024
NOTE 9. PROPERTY, PLANT AND EQUIPMENT
The following table presents the change in the balance of property, plant and equipment for the three-month period ended March 31, 2025 and the twelve-month period ended December 31, 2024:
(US$ MILLIONS) March 31, 2025 December 31, 2024
Gross carrying amount    
Balance at beginning of period $ 3,225  $ 3,398 
Additions (cash and non-cash) 53  182 
Dispositions (16) (39)
Assets reclassified as held for sale —  (2)
Foreign currency translation and other 12  (314)
Balance at end of period $ 3,274  $ 3,225 
Accumulated depreciation and impairment    
Balance at beginning of period $ (745) $ (655)
Depreciation and impairment expense (53) (189)
Dispositions 31 
Assets reclassified as held for sale — 
Foreign currency translation and other (4) 67 
Balance at end of period $ (795) $ (745)
Net book value (1)
$ 2,479  $ 2,480 
____________________________________
(1)Includes right-of-use assets of $234 million as at March 31, 2025 (December 31, 2024: $221 million).
14

NOTES TO UNAUDITED INTERIM CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS

As at March 31, 2025 and December 31, 2024 and
for the three months ended March 31, 2025 and 2024
NOTE 10. INTANGIBLE ASSETS
The following table presents the change in the balance of intangible assets for the three-month period ended March 31, 2025 and the twelve-month period ended December 31, 2024:
(US$ MILLIONS) March 31, 2025 December 31, 2024
Gross carrying amount    
Balance at beginning of period $ 7,650  $ 8,163 
Additions 44  239 
Dispositions (3) (13)
Acquisitions through business combinations —  11 
Foreign currency translation 210  (750)
Balance at end of period $ 7,901  $ 7,650 
Accumulated amortization    
Balance at beginning of period $ (1,684) $ (1,232)
Amortization and impairment expense (143) (614)
Dispositions 12 
Foreign currency translation (44) 150 
Balance at end of period $ (1,870) $ (1,684)
Net book value $ 6,031  $ 5,966 
Included within intangible assets are customer relationship intangible assets pertaining to continuing relationships with many of the company’s customers that contribute to the revenues and cash flows generated by the company’s respective operations. The company has recognized customer relationships from the acquisition of its dealer software and technology services operation in 2022. These customer relationships were valued at the date of acquisition using a multi-period excess earnings approach and have a carrying value of $2.7 billion as at March 31, 2025 (December 31, 2024: $2.7 billion) with a remaining useful life of 13 years.
NOTE 11. GOODWILL
The following table presents the change in the balance of goodwill for the three-month period ended March 31, 2025 and the twelve-month period ended December 31, 2024:
(US$ MILLIONS) March 31, 2025 December 31, 2024
Balance at beginning of period $ 4,988  $ 5,702 
Acquisitions through business combinations —  24 
Impairment losses —  (661)
Foreign currency translation (77)
Balance at end of period $ 4,993  $ 4,988 
NOTE 12. EQUITY ACCOUNTED INVESTMENTS
The following table presents the change in the balance of equity accounted investments for the three-month period ended March 31, 2025 and the twelve-month period ended December 31, 2024:
(US$ MILLIONS) March 31, 2025 December 31, 2024
Balance at beginning of period $ 198  $ 222 
Additions 10  — 
Share of net income (loss)
Distributions received (4) (18)
Foreign currency translation (6) (14)
Balance at end of period $ 201  $ 198 
15

NOTES TO UNAUDITED INTERIM CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS

As at March 31, 2025 and December 31, 2024 and
for the three months ended March 31, 2025 and 2024
NOTE 13. ACCOUNTS PAYABLE AND OTHER
(US$ MILLIONS) March 31, 2025 December 31, 2024
Current    
Accounts payable $ 825  $ 829 
Accrued and other liabilities 1,019  919 
Lease liabilities 45  44 
Financial liabilities (1)
112  122 
Work in progress (2)
378  382 
Provisions and decommissioning liabilities 686  689 
Liabilities associated with assets held for sale
Total current $ 3,070  $ 2,990 
Non-current    
Accounts payable $ 87  $ 81 
Accrued and other liabilities 341  323 
Lease liabilities 245  236 
Financial liabilities (1)
1,258  1,266 
Work in progress (2)
33  36 
Provisions and decommissioning liabilities 337  344 
Total non-current $ 2,301  $ 2,286 
____________________________________
(1)Includes financial liabilities of $1,242 million ($38 million current and $1,204 million non-current) as at March 31, 2025, and $1,255 million ($42 million current and $1,213 million non-current) as at December 31, 2024 related to the failed sale and leaseback of hospitals.
(2)See Note 14 for additional information.
NOTE 14. CONTRACTS IN PROGRESS
(US$ MILLIONS) March 31, 2025 December 31, 2024
Contract costs incurred to date $ 11,888  $ 11,015 
Profit recognized to date (less recognized losses) 189  155 
$ 12,077  $ 11,170 
Less: progress billings (12,351) (11,450)
Contract work in progress (liability) $ (274) $ (280)
Comprising:    
Amounts due from customers – work in progress $ 137  $ 138 
Amounts due to customers – creditors (411) (418)
Net work in progress $ (274) $ (280)
16

NOTES TO UNAUDITED INTERIM CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS

As at March 31, 2025 and December 31, 2024 and
for the three months ended March 31, 2025 and 2024
NOTE 15. BORROWINGS
Current and non-current non-recourse borrowings in subsidiaries of the company as at March 31, 2025, net of deferred financing costs, premiums and discounts were $146 million and $8,565 million (December 31, 2024: $111 million and $8,379 million). Non-recourse borrowings in subsidiaries of the company include borrowings made under subscription facilities of Brookfield-sponsored private equity funds.
The company has financing arrangements within its operating businesses that trade in public markets or are held at major financial institutions. The financing arrangements are primarily composed of term loans, credit facilities, and notes and debentures which are subject to fixed or floating rates. Most of these borrowings are not subject to financial maintenance covenants, however, some are subject to fixed charge coverage, leverage ratios and minimum equity or liquidity covenants.
As at March 31, 2025, the company’s operations were in compliance with or had obtained waivers related to all material covenant requirements, and the company continues to work with its subsidiaries to monitor performance against such covenant requirements. Earlier this year, the company’s healthcare services operation obtained forbearance from its lenders providing the business with temporary interest relief under its financing agreements. Operating performance continues to be under pressure and the current capital structure is unsustainable. The business is assessing options as it continues to negotiate with key stakeholders.
NOTE 16. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
Attributable to Brookfield Business Partners
The following tables present the changes in accumulated other comprehensive income (loss) reserves attributable to Brookfield Business Partners for the three-month period ended March 31, 2025 and 2024:
(US$ MILLIONS) Foreign currency
translation
Other (1)
Accumulated other
comprehensive
income (loss)
Balance as at January 1, 2025 $ (547) $ 125  $ (422)
Other comprehensive income (loss) 25  (19)
Balance as at March 31, 2025 $ (522) $ 106  $ (416)
____________________________________
(1)Represents net investment hedges, cash flow hedges and other reserves.
(US$ MILLIONS) Foreign currency
translation
Other (1)
Accumulated other
comprehensive
income (loss)
Balance as at January 1, 2024 $ (427) $ 62  $ (365)
Other comprehensive income (loss) (34) 12  (22)
Balance as at March 31, 2024 $ (461) $ 74  $ (387)
____________________________________
(1)Represents net investment hedges, cash flow hedges and other reserves.
17

NOTES TO UNAUDITED INTERIM CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS

As at March 31, 2025 and December 31, 2024 and
for the three months ended March 31, 2025 and 2024
NOTE 17. DIRECT OPERATING COSTS
The company has no key employees or directors and does not remunerate key management personnel. Key decision makers of the company are all employees of Brookfield or its subsidiaries, which provide management services under the Master Services Agreement with Brookfield (“Master Services Agreement”). Details of the allocations of costs incurred by Brookfield on behalf of the company are disclosed in Note 20.
Direct operating costs are costs incurred to earn revenues and include all attributable expenses. The following table presents direct operating costs by nature for the three months ended March 31, 2025 and 2024:
Three Months Ended
March 31,
(US$ MILLIONS) 2025 2024
Inventory costs $ 107  $ 122 
Subcontractor and consultant costs 680  597 
Concession construction materials and labor costs 36  40 
Depreciation and amortization expense 196  196 
Compensation 470  439 
Other direct costs 300  258 
Total $ 1,789  $ 1,652 
Other direct costs include freight, cost of construction expensed and expected credit loss provisions on financial assets.
NOTE 18. REVENUES
(a)Timing of recognition of revenues from contracts with customers
The following table summarizes the company’s revenues by timing of revenue recognition for the total revenues from contracts with customers for the three months ended March 31, 2025 and 2024.
Three Months Ended March 31,
(US$ MILLIONS) 2025 2024
Timing of revenue recognition
Goods and services provided at a point in time $ 672  $ 714 
Services transferred over a period of time 1,294  1,151 
Total revenues from contracts with customers 1,966  1,865 
(b)Revenues by geography
The following table summarizes the company’s total revenues by geography for the three months ended March 31, 2025 and March 31, 2024:
Three Months Ended March 31,
(US$ MILLIONS) 2025 2024
Australia $ 983  $ 919 
United States of America 411  454 
United Kingdom 312  213 
Brazil 180  206 
Canada 70  70 
Other 10 
Total revenues from contracts with customers $ 1,966  $ 1,865 
18

NOTES TO UNAUDITED INTERIM CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS

As at March 31, 2025 and December 31, 2024 and
for the three months ended March 31, 2025 and 2024
NOTE 19. EQUITY
The following table provides a continuity of the company’s outstanding equity for the three-month period ended March 31, 2025:
Class C shares
Shares outstanding (Shares) Share capital
(US$ Millions)
Balance as at January 1, 2025 25,934,120  $ 737 
Contributions —  33 
Balance as at March 31, 2025 25,934,120  $ 770 
The company’s share capital is comprised of exchangeable shares, class B shares and class C shares. Due to the exchange feature of the exchangeable shares and the cash redemption feature of the class B and class C shares, the exchangeable shares, the class B shares, and the class C shares are classified as financial liabilities. However, the class C shares, the most subordinated of all of the company’s classes of common shares, meet certain qualifying criteria and are presented as equity instruments given the narrow scope presentation exceptions existing in IAS 32. Refer to Note 5 for further details related to the exchangeable shares and the class B shares.
NOTE 20. RELATED PARTY TRANSACTIONS
In the normal course of operations, the company entered into the transactions below with related parties. The ultimate parent of the company is Brookfield Corporation. Other related parties of the company represent Brookfield Corporation’s subsidiaries, affiliates, and operating entities.
Pursuant to the Master Services Agreement, on a quarterly basis, the Service Recipients pay a base management fee, referred to as the Base Management Fee, to Service Providers, equal to 0.3125% per quarter (1.25% annually) of the total capitalization of Brookfield Business Partners. For purposes of calculating the Base Management Fee, the total capitalization of Brookfield Business Partners is equal to the quarterly volume-weighted average trading price of an LP Unit on the principal stock exchange for the LP Units (based on trading volumes) multiplied by the number of LP Units outstanding at the end of the quarter (assuming full conversion of the Redemption-Exchange Units into LP Units of Brookfield Business Partners L.P.), plus the value of securities of the other service recipients (including the exchangeable shares) that are not held by Brookfield Business Partners, plus all outstanding debt with recourse to a service recipient, less all cash held by such entities.
The company is responsible for paying its proportionate share of the total Base Management Fee in connection with the Master Services Agreement. The Base Management Fee attributable to the company for the three month period ended March 31, 2025 was $7 million (March 31, 2024: $6 million). The expense related to the services received under the Master Services Agreement has been recorded as part of general and administrative expenses in the unaudited interim condensed consolidated statements of operating results.
An integral part of the company’s strategy is to participate with institutional investors in Brookfield-sponsored private equity funds that target acquisitions that suit the company’s investment mandate. In the normal course of business, the group and institutional investors have made commitments to Brookfield-sponsored private equity funds, and in connection therewith, the group, together with institutional investors, has access to short-term financing using the private equity funds’ credit facilities to facilitate investments that Brookfield has determined to be in the group’s best interests.
In addition, Brookfield has entered into indemnity agreements with the company related to certain construction projects in the Middle East region that were in place prior to the creation of Brookfield Business Partners. Under these indemnity agreements, Brookfield has agreed to indemnify or refund the company, as appropriate, for the receipt of payments relating to such projects.
19

NOTES TO UNAUDITED INTERIM CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS

As at March 31, 2025 and December 31, 2024 and
for the three months ended March 31, 2025 and 2024
Brookfield entered into a commitment agreement with the partnership in 2022 to subscribe for up to $1.5 billion of perpetual preferred equity securities of subsidiaries of the partnership (including subsidiaries of the company). Brookfield will have the right to cause the company or Brookfield Business Partners to redeem the preferred securities at par plus accrued and unpaid dividends to the extent of any net proceeds received by the company or Brookfield Business Partners from the issuance of equity, incurrence of indebtedness or sale of assets. Brookfield has the right to waive its redemption option. As at March 31, 2025, the amount subscribed from the company was $nil (December 31, 2024: $nil) and the amount subscribed from Brookfield Business Partners was $725 million (December 31, 2024: $725 million) with an annual dividend of 7%. The remaining capacity available on the commitment agreement with Brookfield is $25 million.
The company has entered into two credit agreements with Brookfield Business Partners, one as borrower and one as lender, each providing for a ten-year revolving $1 billion credit facility, maturing on March 15, 2032 (unless terminated by the lender in accordance with the agreement after the fifth anniversary), to facilitate the movement of cash within the group. The credit agreement under which the company is the borrower permits it to borrow up to $1 billion from Brookfield Business Partners, and the other permits Brookfield Business Partners to borrow up to $1 billion from the company. Each credit facility contemplates a deposit arrangement pursuant to which the lender thereunder would, with the consent of the borrower, deposit funds on a demand basis to such borrower’s account at a reduced rate of interest. As at March 31, 2025, the net amount outstanding on deposit is $509 million payable to Brookfield Business Partners included in accounts payable and other (December 31, 2024: $470 million payable to Brookfield Business Partners).
Brookfield Business Partners provided the company an equity commitment in the amount of $2 billion. The equity commitment may be called by the company in exchange for the issuance of a number of class C shares or preferred shares, as the case may be, to Brookfield Business Partners, corresponding to the amount of the equity commitment called divided (i) in the case of a subscription for class C shares, by the volume-weighted average of the trading price for one exchangeable share on the principal stock exchange on which the exchangeable shares are listed for the five (5) days immediately preceding the date of the call, and (ii) in the case of a subscription for preferred shares, by $25.00 per share. The equity commitment will be available in minimum amounts of $10 million and the amount available under the equity commitment will be reduced permanently by the amount so called. Before funds may be called on the equity commitment, a number of conditions precedent must be met, including that Brookfield Business Partners continues to control the company and has the ability to elect a majority of the Board of Directors.
From time to time, Brookfield may place funds on deposit with Brookfield Business Partners and the company, on terms approved by the independent directors of the company. Interest earned or incurred on such deposits is at market terms. As at March 31, 2025, the deposit from Brookfield was $nil (December 31, 2024: $nil) and the company incurred interest expense of $nil for the three months ended March 31, 2025 on these deposits (March 31, 2024: $nil).
A wholly-owned subsidiary of the company fully and unconditionally guaranteed the obligations of Brookfield Business Partners under Brookfield Business Partners’ $2.35 billion bilateral credit facilities with global banks and its $1 billion revolving acquisition credit facility with Brookfield.
As at March 31, 2025, the company had a loan receivable of $1.1 billion from Brookfield Business Partners in connection with the proceeds received from the disposition of the company’s nuclear technology services operation in 2023. The loan receivable is non-interest bearing and is due on demand and included in accounts and other receivable, net.
The following table summarizes revenues the company has earned from transactions with related parties for the three month periods ended March 31, 2025 and 2024:
Three Months Ended
March 31,
(US$ MILLIONS) 2025 2024
Transactions during the period
Revenues (1)
$ 44  $ 27 
____________________________________
(1)The company provides construction services to affiliates of Brookfield.
The following table summarizes balances with related parties as at March 31, 2025 and December 31, 2024:
20

NOTES TO UNAUDITED INTERIM CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS

As at March 31, 2025 and December 31, 2024 and
for the three months ended March 31, 2025 and 2024
(US$ MILLIONS) March 31, 2025 December 31, 2024
Balances at end of period:
Accounts and other receivable, net $ 1,430  $ 1,431 
Accounts payable and other 531  473 
Non-recourse borrowings in subsidiaries of the company 44  44 
NOTE 21. DERIVATIVE FINANCIAL INSTRUMENTS
The company’s activities expose it to a variety of financial risks, including market risk (currency risk and interest rate risk) and liquidity risk. The company and its subsidiaries selectively use derivative financial instruments principally to manage these risks.
The aggregate fair values of the company’s derivative financial instruments are as follows:
March 31, 2025 December 31, 2024
(US$ MILLIONS) Financial Assets Financial Liabilities Financial Assets Financial Liabilities
Foreign exchange contracts $ 81  $ (24) $ 104  $ (36)
Cross currency swaps 24  (12) 30  (14)
Interest rate derivatives 27  (5) 50  (5)
Total $ 132  $ (41) $ 184  $ (55)
Total current $ 84  $ (35) $ 106  $ (46)
Total non-current $ 48  $ (6) $ 78  $ (9)
NOTE 22. SUPPLEMENTAL CASH FLOW INFORMATION
  Three Months Ended
March 31,
(US$ MILLIONS) 2025 2024
Net interest paid (received) $ 138  $ 144 
Net income taxes paid (received) 41 
Amounts paid and received for interest were reflected as operating cash flows in the unaudited interim condensed consolidated statements of cash flow.
Details of “Changes in non-cash working capital, net” on the unaudited interim condensed consolidated statements of cash flow are as follows:
  Three Months Ended
March 31,
(US$ MILLIONS) 2025 2024
Accounts receivable $ (75) $ (221)
Inventory (7) — 
Prepayments and other (23)
Accounts payable and other (7) 106 
Changes in non-cash working capital, net $ (112) $ (109)
NOTE 23. SUBSEQUENT EVENTS
(a)Dividend
On April 30, 2025, the Board of Directors declared a quarterly dividend in the amount of $0.0625 per exchangeable share, payable on June 30, 2025 to shareholders of record as at the close of business on May 30, 2025.
21

MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Introduction
The following Management’s Discussion and Analysis (“MD&A”) is the responsibility of management of Brookfield Business Corporation (our “company”). This MD&A is dated May 6, 2025 and has been approved by the Board of Directors of our company (the “Board of Directors”) for issuance as of that date. The Board of Directors carries out its responsibility for review of this document principally through its audit committee, comprised exclusively of independent directors. The audit committee reviews and, prior to its publication, approves this MD&A, pursuant to the authority delegated to it by the Board of Directors. The terms “we”, “us” and “our” refer to Brookfield Business Corporation, and our company’s direct and indirect operating entities as a group. This MD&A should be read in conjunction with our company’s most recently issued annual financial statements. Additional information is available on our website at https://bbu.brookfield.com/bbuc/overview, on SEDAR+ at www.sedarplus.ca and on EDGAR’s website at www.sec.gov.
The class A exchangeable subordinate voting shares (each, an “exchangeable share”) of our company are structured with the intention of being economically equivalent to the non-voting limited partnership units (“LP Units”) of Brookfield Business Partners L.P. (NYSE: BBU; TSX: BBU.UN) (the “partnership”, the “parent company” or, collectively with its subsidiaries, but excluding our company, “Brookfield Business Partners”). Brookfield Business Partners, our company and respective subsidiaries are referred to collectively as our “group”. Brookfield Corporation (“Brookfield Corporation” or together with its controlled subsidiaries, excluding the group, “Brookfield”), is the ultimate parent of the company and the group. “Brookfield Holders” refers to Brookfield, Brookfield Wealth Solutions Ltd. (“Brookfield Wealth Solutions”) and their related parties. We believe economic equivalence is achieved through targeting identical dividends and distributions on the exchangeable shares and the LP Units and each exchangeable share being exchangeable at the option of the holder for one LP Unit of the partnership at any time. Given the economic equivalence, we expect that the market price of the exchangeable shares will be significantly impacted by the market price of the LP Units and the combined business performance of our company and Brookfield Business Partners as a whole. In addition to carefully considering the disclosures made in this document, shareholders are strongly encouraged to carefully review the partnership’s periodic reporting, including the partnership’s unaudited interim condensed consolidated financial statements and MD&A for the three months ended March 31, 2025. The partnership is required to file reports, including annual reports on Form 20-F and interim reports that are filed on Form 6-K, and other information with the United States Securities and Exchange Commission (the “SEC”). The partnership’s SEC filings are available to the public from the SEC’s website at http://www.sec.gov. Copies of documents that have been filed with the Canadian securities authorities can be obtained at www.sedarplus.ca. Information about the partnership, including its SEC filings, is also available on its website at https://bbu.brookfield.com. The information found on, or accessible through, https://bbu.brookfield.com is not incorporated into and does not form a part of this MD&A.
In addition to historical information, this MD&A contains forward-looking statements. Readers are cautioned that these forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements. See “Cautionary Statements Regarding Forward-Looking Statements”.
Cautionary Statement Regarding Forward-Looking Statements and Information
This MD&A contains “forward-looking information” within the meaning of Canadian provincial securities laws and “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws, including the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements that are predictive in nature, depend upon or refer to future events or conditions, include statements regarding the operations, business, financial condition, expected financial results, performance, prospects, opportunities, priorities, targets, goals, ongoing objectives, strategies and outlook of our group, as well as regarding recently completed and proposed acquisitions, dispositions and other transactions, and the outlook for North American and international economies for the current fiscal year and subsequent periods, and include words such as “expects”, “anticipates”, “plans”, “believes”, “estimates”, “seeks”, “intends”, “targets”, “projects”, “forecasts”, “views”, “potential”, “likely” or negative versions thereof and other similar expressions, or future or conditional verbs such as “may”, “will”, “should”, “would” and “could”.
Although we believe that our anticipated future results, performance or achievements expressed or implied by the forward-looking statements and information are based upon reasonable assumptions and expectations, investors and other readers should not place undue reliance on forward-looking statements and information because they involve assumptions, known and unknown risks, uncertainties and other factors, many of which are beyond our control, which may cause the actual results, performance or achievements of our group to differ materially from anticipated future results, performance or achievements expressed or implied by such forward-looking statements and information. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us or are within our control. If a change occurs, our business, financial condition, liquidity and result of operations and our plans and strategies may vary materially from those expressed in the forward-looking statements and forward-looking information herein.
1


Factors that could cause actual results to differ materially from those contemplated or implied by forward-looking statements include, but are not limited to, the following:
•the cyclical nature of our operating businesses and general economic conditions and risks relating to the economy, including unfavorable changes in interest rates, foreign exchange rates, inflation, commodity prices, and volatility in the financial markets;
•the ability to complete and effectively integrate acquisitions into existing operations and the ability to attain expected benefits;
•business competition, including competition for acquisition opportunities;
•strategic actions including our ability to complete dispositions and achieve the anticipated benefits therefrom;
•restrictions on our ability to engage in certain activities or make distributions due to our indebtedness;
•global equity and capital markets and the availability of equity and debt financing and refinancing within these markets;
•changes to our credit ratings;
•changes to U.S. laws or policies, including changes in U.S. domestic and economic policies as well as foreign trade policies and tariffs;
•technological change;
•the ability to obtain insurance for our business operations;
•labor disruptions and economically unfavorable collective bargaining agreements;
•litigation;
•investments in jurisdictions with less developed legal systems;
•our group does not have control over all of the businesses in which we own investments;
•changes to the market price of any investments in public companies;
•our compliance with environmental laws and the broader impacts of climate change;
•cybersecurity incidents;
•the possible impact of international conflicts, wars and related developments including terrorist acts and cyber terrorism;
•the effectiveness of our internal controls over financial reporting;
•the market price of the exchangeable shares and units may be volatile;
•political instability and unfamiliar cultural factors;
•changes in government policy and legislation;
•federal, state and foreign anti-corruption and trade sanctions laws and restrictions on foreign direct investment applicable to us and our group’s operating businesses create the potential for significant liabilities and penalties, the inability to complete transactions, imposition of significant costs and burdens, and reputational harm;
•operational or business risks that are specific to any of our operating businesses;
•reliance on third party service providers;
•catastrophic events, such as earthquakes, hurricanes and pandemics/epidemics;
•Brookfield’s significant influence over our group;
•the lack of an obligation of Brookfield to source acquisition opportunities to our group;
•the departure of some or all of Brookfield’s professionals;
2


•control of our company, the partnership or the general partner of the partnership may change without unitholder or shareholder consent;
•Brookfield may increase its ownership in our company;
•the Master Services Agreement and our group’s other arrangements with Brookfield do not impose on Brookfield any fiduciary duties to act in the best interests of our shareholders;
•conflicts of interest between our company and our shareholders, on the one hand, and Brookfield, on the other hand;
•our arrangements with Brookfield may contain terms that are less favorable than those which otherwise might have been unrelated parties;
•our company is not entitled to terminate the Master Services Agreement and the general partner of the partnership may be unable or unwilling to do so;
•the limited liability of, and our company’s indemnification of, the Service Providers;
•Brookfield’s relationship with Oaktree Capital Group, LLC, together with its affiliates;
•our company may become regulated as an investment company under the U.S. Investment Company Act of 1940, as amended;
•future sales or issuances of our securities will result in dilution of existing holders and even the perception of such sales or issuances taking place could depress the trading price of the exchangeable shares;
•limits on shareholders’ ability to obtain favorable judicial forum for disputes related to Brookfield Business Partners or to enforce judgements against our group;
•changes in tax law and practice; and
•other risks and factors detailed from time to time in our documents filed with the securities regulators in Canada and the United States including those set forth in the “Risk Factors” section in our annual report on Form 20-F for the year ended December 31, 2024 (our “2024 Annual Report”).
Statements relating to “reserves” are deemed to be forward-looking statements as they involve the implied assessment, based on certain estimates and assumptions, that the reserves described herein can be profitably produced in the future.
We caution that the foregoing list of important factors that may affect future results is not exhaustive. When relying on our forward-looking statements and information, investors and others should carefully consider the foregoing factors and other uncertainties and potential events.
For a more comprehensive list of risks and uncertainties, please refer to our 2024 Annual Report under the heading “Risk Factors” available on SEDAR+ at www.sedarplus.ca and EDGAR at www.sec.gov. New risk factors may arise from time to time and it is not possible to predict all of those risk factors or the extent to which any factor or combination of factors may cause actual results, performance or achievements of our company to be materially different from those contained in forward-looking statements or information. Given these risks, assumptions and uncertainties, the reader should not place undue reliance on forward-looking statements or information as a prediction of actual results. We qualify any and all of our forward looking statements by these cautionary factors. Although the forward-looking statements and information contained in this MD&A are based upon what we believe to be reasonable assumptions, we cannot assure investors that actual results will be consistent with these forward-looking statements and information. We undertake no obligation to publicly update or revise any forward-looking statements or information, whether written or oral, that may be as a result of new information, future events or otherwise, except as required by law.
Basis of Presentation
The financial information in this MD&A is derived from the financial information included in the unaudited interim condensed consolidated financial statements of our company, prepared in accordance with IAS 34, Interim Financial Reporting (“IAS 34”), as issued by the International Accounting Standards Board (“IASB”), and using the accounting policies our company applied in its annual consolidated financial statements as at and for the year ended December 31, 2024. All defined terms are also described in the annual consolidated financial statements. The unaudited interim condensed consolidated financial statements are prepared on a going concern basis and have been presented in U.S. dollars rounded to the nearest million unless otherwise indicated. The unaudited interim condensed consolidated financial statements include the accounts of our company and its consolidated subsidiaries, which are the entities over which our company has control.
3


Overview of Our Company
Our company is a Canadian corporation established by Brookfield Business Partners as an alternative vehicle for investors who prefer investing in our group’s operations through a corporate structure. Each exchangeable share of our company is exchangeable at the option of the holder for one LP Unit or its cash equivalent and structured with the intention of providing an economic return equivalent to one LP Unit. Through our operating subsidiaries, we own and operate high-quality services and industrial operations that benefit from a strong competitive position and provide essential products and services. We seek to build value by pursuing an operations-oriented approach to enhancing cash flows and opportunistically recycling capital to grow our existing operations and make new acquisitions. We strive to ensure that all our operations have a clear, concise business strategy built on competitive advantages, while focusing on profitability and the sustainability of cash flows.
Review of Consolidated Results of Operations
The table below summarizes our results of operations for the three months ended March 31, 2025 and 2024:
  Three Months Ended
March 31,
(US$ MILLIONS) 2025 2024
Revenues $ 1,966  $ 1,865 
Direct operating costs (1,789) (1,652)
General and administrative expenses (75) (64)
Interest income (expense), net (219) (210)
Equity accounted income (loss)
Impairment reversal (expense), net —  (2)
Remeasurement of exchangeable and class B shares (7) (111)
Other income (expense), net (34) (11)
Income (loss) before income tax (155) (184)
Income tax (expense) recovery
Current
(23) (44)
Deferred 43  54 
Net income (loss) $ (135) $ (174)
Attributable to:
Brookfield Business Partners $ (58) $ (150)
Non-controlling interests (77) (24)
$ (135) $ (174)
Comparison of the three months ended March 31, 2025 and 2024
For the three months ended March 31, 2025, net loss decreased by $39 million to $135 million, compared to $174 million for the three months ended March 31, 2024. Current period results included a remeasurement loss on our exchangeable and class B shares that are classified as liabilities under IFRS® Accounting Standards. As at March 31, 2025, the exchangeable and class B shares were remeasured to reflect the closing price of $23.46 per unit.
Revenues
Revenues for the three months ended March 31, 2025 of $1,966 million increased by $101 million, compared to $1,865 million for the three months ended March 31, 2024. Results benefited from higher revenues in our construction operation due to increased activity, partially offset by lower revenues in our dealer software and technology services operation.
Direct operating costs
For the three months ended March 31, 2025, direct operating costs increased by $137 million to $1,789 million, compared to $1,652 million for the three months ended March 31, 2024. The increase was primarily due to higher costs within our construction operation as a result of increased activity.
4


General and administrative expenses
For the three months ended March 31, 2025, general and administrative expenses increased by $11 million to $75 million, compared to $64 million for the three months ended March 31, 2024 primarily due to higher costs in our dealer software and technology services operation.
Interest income (expense), net
For the three months ended March 31, 2025, interest expense, net increased by $9 million to $219 million, compared to $210 million for the three months ended March 31, 2024. The increase was primarily due to interest expense incurred on deposits received from Brookfield Business Partners under the credit agreement as described in Note 20 of the unaudited interim condensed consolidated financial statements. Interest expense includes $4 million of dividends declared on the exchangeable shares (March 31, 2024: $5 million).
Remeasurement of exchangeable and class B shares
For the three months ended March 31, 2025, the remeasurement loss on exchangeable shares and class B shares was $7 million compared to $111 million for the three months ended March 31, 2024. The exchangeable shares and class B shares were remeasured to reflect the closing price of one LP Unit, valued at $23.46 per unit as at March 31, 2025.
Other income (expense), net
For the three months ended March 31, 2025, net other expense increased by $23 million to $34 million, compared to $11 million for the three months ended March 31, 2024. For the three months ended March 31, 2025, the components of other income (expense), net include $12 million of business separation expenses, stand-up costs and restructuring charges and $22 million of other expenses. For the three months ended March 31, 2024, the components of other income (expense), net include $10 million of net revaluation gains and $21 million of other expenses.
Income tax (expense) recovery
For the three months ended March 31, 2025, current income tax expense decreased by $21 million to $23 million, compared to $44 million for the three months ended March 31, 2024. The decrease in current income tax expense was primarily due to lower taxable income within our dealer software and technology services operation combined with a decrease in current income tax expense in our construction operation due to utilization of tax losses relating to a prior period.
Deferred income tax recovery for the three months ended March 31, 2025 decreased by $11 million to $43 million, compared to $54 million for the three months ended March 31, 2024. The decrease in deferred income tax recovery was primarily due to utilization of tax losses in our construction operation.
5


Summary of Results
Quarterly results
Total revenues and net income (loss) for the eight most recent quarters were as follows:
2025 2024 2023
(US$ MILLIONS) Q1 Q4 Q3 Q2 Q1 Q4 Q3 Q2
Revenues $ 1,966  $ 2,209  $ 2,205  $ 1,929  $ 1,865  $ 1,946  $ 1,964  $ 1,908 
Direct operating costs (1,789) (2,041) (2,015) (1,860) (1,652) (1,749) (1,760) (1,669)
General and administrative expenses (75) (107) (78) (77) (64) (78) (66) (63)
Interest income (expense), net (219) (212) (207) (203) (210) (206) (227) (233)
Equity accounted income (loss)
Impairment reversal (expense), net —  (689) —  —  (2) (599) —  (7)
Gain (loss) on acquisitions/dispositions, net —  —  —  —  —  —  —  87 
Remeasurement of exchangeable and Class B shares (7) (9) (325) 237  (111) (392) 148  101 
Other income (expense), net (34) (469) (127) (59) (11) 44  (51) 171 
Income (loss) before income tax (155) (1,316) (544) (31) (184) (1,032) 297 
Income tax (expense) recovery
Current (23) (8) (14) 16  (44) (5) (40) (112)
Deferred 43  42  47  55  54  71  10 
Net income (loss) from continuing operations $ (135) $ (1,282) $ (511) $ 40  $ (174) $ (1,036) $ 40  $ 195 
Discontinued operations:
Net income (loss) from discontinued operations(1)
—  —  —  —  —  3,885  (33) (37)
Net income (loss) $ (135) $ (1,282) $ (511) $ 40  $ (174) $ 2,849  $ $ 158 
Attributable to:
Brookfield Business Partners $ (58) $ (396) $ (466) $ 124  $ (150) $ 454  $ 97  $ 108 
Non-controlling interests (77) (886) (45) (84) (24) 2,395  (90) 50 
$ (135) $ (1,282) $ (511) $ 40  $ (174) $ 2,849  $ $ 158 
____________________________________
(1)Relates to our former investment in a nuclear technology services operation which was sold in November 2023.
Revenues and operating costs vary from quarter to quarter primarily due to acquisitions and dispositions of businesses, fluctuations in foreign exchange rates, business and economic cycles, weather and seasonality, broader economic factors and commodity market volatility. Net income is impacted by periodic monetization gains, impairment losses and gains or losses on remeasurement of exchangeable shares.
6


Review of Consolidated Financial Position
The following table is a summary of the unaudited interim condensed consolidated statements of financial position as at March 31, 2025 and December 31, 2024:
Change
(US$ MILLIONS) March 31, 2025 December 31, 2024
March 31, 2025 vs December 31, 2024
Assets  
Cash and cash equivalents $ 968  $ 1,008  $ (40)
Financial assets 324  353  (29)
Accounts and other receivable, net 3,397  3,229  168 
Inventory, net 59  52 
Other assets 641  627  14 
Property, plant and equipment 2,479  2,480  (1)
Deferred income tax assets 206  197 
Intangible assets 6,031  5,966  65 
Equity accounted investments 201  198 
Goodwill 4,993  4,988 
$ 19,299  $ 19,098  $ 201 
Liabilities and Equity  
Liabilities  
Accounts payable and other $ 5,371  $ 5,276  $ 95 
Non-recourse borrowings in subsidiaries of the company 8,711  8,490  221 
Exchangeable and class B shares 1,682  1,709  (27)
Deferred income tax liabilities 951  988  (37)
$ 16,715  $ 16,463  $ 252 
Equity
Brookfield Business Partners $ (78) $ (59) $ (19)
Non-controlling interests 2,662  2,694  (32)
2,584  2,635  (51)
$ 19,299  $ 19,098  $ 201 
Financial assets
Financial assets decreased by $29 million to $324 million as at March 31, 2025, compared to $353 million as at December 31, 2024. The balance comprised loans and notes receivable, derivative contracts, restricted cash, and other financial assets. The decrease was primarily due to fair value movements in derivative assets at our dealer software and technology services operation and our water and wastewater operation.
Accounts receivable and other, net
Accounts receivable and other, net increased by $168 million to $3,397 million as at March 31, 2025, compared to $3,229 million as at December 31, 2024. The increase was primarily due to timing of billed receivables in our construction operation and the impact of foreign currency movements within our operations.
Property, plant & equipment and intangible assets
PP&E decreased by $1 million to $2,479 million as at March 31, 2025, compared to $2,480 million as at December 31, 2024. This was primarily due to regular depreciation expense of $53 million which was mostly offset by net additions to PP&E and the impact of foreign exchange movements. As at March 31, 2025, PP&E included $234 million of right-of-use assets (December 31, 2024: $221 million).
7


Intangible assets increased by $65 million to $6,031 million as at March 31, 2025, compared to $5,966 million as at December 31, 2024. The increase was primarily due to the impact of foreign exchange movements of $166 million and net additions of $42 million primarily at our water and wastewater operation, partially offset by $143 million of regular amortization expense.
Capital expenditures represent additions to PP&E and certain intangible assets. Included in capital expenditures are maintenance capital expenditures, which are required to sustain the current performance of our operations, and growth capital expenditures, which are made for incrementally new assets that are expected to expand existing operations. Capital expenditures were primarily related to production costs associated with developing or enhancing proprietary technology as well as maintenance of computer and hosting equipment at our dealer software and technology services operation and maintenance and improvements on hospital facilities and new hospital equipment at our healthcare services. In addition, we included additions to intangible assets in our water and wastewater operation within capital expenditures due to the nature of its concession agreements. Maintenance and growth capital expenditures for the three months ended March 31, 2025 were $20 million and $36 million, respectively (March 31, 2024: $26 million and $48 million, respectively).
Accounts payable and other
Accounts payable and other increased by $95 million to $5,371 million as at March 31, 2025, compared to $5,276 million as at December 31, 2024. The increase was primarily due to higher accrued and other liabilities in our dealer software and technology services operation and the impact of foreign currency movements within our operations.
Non-recourse borrowings in subsidiaries of the company
Borrowings are discussed in “Liquidity and Capital Resources”.
Equity
On August 15, 2024, the TSX accepted a notice filed by our company of its intention to renew its normal course issuer bid (“NCIB”) for its exchangeable shares. Under the NCIB, our company is authorized to repurchase up to 5% of its issued and outstanding exchangeable shares as at August 8, 2024 or 3,647,722 shares, including up to 5,184 shares on the TSX during any trading day.
During the three months ended March 31, 2025, our company repurchased 1,260,225 exchangeable shares (March 31, 2024: nil). Following the three months ended March 31, 2025 and up to the date of this MD&A, our company repurchased 1,045,142 exchangeable shares under the NCIB.
During the three months ended March 31, 2025, 154 exchangeable shares were exchanged into LP Units (March 31, 2024: 1).
As at March 31, 2025, Brookfield Holders owned approximately 66% of the issued and outstanding exchangeable shares.
Summary Financial Information Related to the Partnership
As the market price of the exchangeable shares is expected to be significantly impacted by the market price of the LP Units and the combined business performance of our group as a whole, we are providing the following summary financial information regarding the partnership. For further details, please review the partnership’s periodic reporting referenced in the introductory section of this MD&A.
(US$ MILLIONS) Three Months Ended
March 31,
IFRS Measures 2025 2024
Revenues $ 6,749  $ 12,015 
Net income (loss) 256  203 
(US$ MILLIONS) As at
IFRS Measures March 31, 2025 December 31, 2024
Total assets $ 75,887  $ 75,474 
Total liabilities 61,032  58,166 
Total equity 14,855  17,308 
8


(US$ MILLIONS) Three Months Ended
March 31,
Non-IFRS Measure 2025 2024
Adjusted EBITDA (1)
$ 591  $ 544 
____________________________________
(1)The partnership’s definition of this non-IFRS financial measure is included within the partnership’s periodic reporting referenced in the introductory section of this MD&A.
Liquidity and Capital Resources
Liquidity and capital requirements are managed through cash flows from operations, use of credit facilities, opportunistically monetizing mature operations and refinancing existing debt. We aim to maintain sufficient financial liquidity to meet our ongoing operating requirements and to fund debt service payments, recurring expenses, required capital expenditures, and acquisition opportunities as they arise. In addition, an integral part of our strategy is to pursue acquisitions through Brookfield-led consortium arrangements with institutional partners or strategic partners, and to form partnerships to pursue acquisitions on a specialized or global basis. Brookfield has an established track record of leading such consortiums and partnerships and actively managing underlying assets to improve performance. Overall, we believe that our liquidity profile is strong, positioning us and our businesses well to take advantage of accretive investment opportunities.
Our principal sources of liquidity are financial assets, undrawn credit facilities, cash flow from our operations and monetizations of mature businesses, and access to public and private capital markets.
As at March 31, 2025, the outstanding non-recourse borrowings in subsidiaries of our company were $8,711 million compared to $8,490 million as at December 31, 2024. Non-recourse borrowings in subsidiaries of our company comprised the following:
(US$ MILLIONS) March 31, 2025 December 31, 2024
Term loans $ 5,006  $ 4,991 
Notes and debentures 2,746  2,616 
Project financing 788  746 
Credit facilities (1)
171  137 
Total non-recourse borrowings in subsidiaries $ 8,711  $ 8,490 
____________________________________
(1)Includes borrowings made under subscription facilities of Brookfield-sponsored private equity funds.
We principally finance our assets at the operating company level with debt that is non-recourse to both our company and to our other operations and is generally secured against assets within the respective operating companies. Moreover, debt instruments at the operating company level do not cross-accelerate or cross-default to debt at other operating companies. This debt is in the form of revolving credit facilities and term loans with variable interest rates, and notes and debentures with fixed interest rates, with varying maturities ranging from less than one year to 23 years. Borrowings increased by $221 million between March 31, 2025 and December 31, 2024, primarily due to increased borrowings at our water and wastewater operation and the impact of foreign exchange movements within our operations.
The use of credit facilities, term loans and debt securities is primarily related to ongoing operations, capital expenditures and to fund acquisitions. Interest rates charged on these facilities are based on market interest rates. The majority of borrowings drawn are not subject to financial maintenance covenants, however, some are subject to fixed charge coverage, leverage ratios and minimum equity or liquidity covenants. As at March 31, 2025, the company’s operations were in compliance with or had obtained waivers related to all material covenant requirements and we continue to work with our businesses to monitor performance against such covenant requirements. Earlier this year, our healthcare services operation obtained forbearance from its lenders providing the business with temporary interest relief under its financing agreements. Operating performance continues to be under pressure and the current capital structure is unsustainable. The business is assessing options as it continues to negotiate with key stakeholders.
The partnership has provided our company with an equity commitment in the amount of $2 billion in order to provide our company with access to equity capital on an as-needed basis and to maximize our flexibility.
9


Our company has also entered into two credit facilities with Brookfield Business Partners, one as borrower and one as lender, each providing for a ten-year revolving credit facility for purposes of providing our company and Brookfield Business Partners with access to debt financing on an as-needed basis and to maximize our flexibility and facilitate the movement of cash within our group. Our company may also establish credit facilities with one or more arm’s length banks. We intend to use the liquidity provided by the credit facilities for working capital purposes. Each credit facility contemplates potential deposit arrangements pursuant to which the lender thereunder would, with the consent of the borrower, deposit funds on a demand basis. As at March 31, 2025, the amount outstanding on deposit is $509 million payable to Brookfield Business Partners included in accounts payable and other (December 31, 2024: payable to Brookfield Business Partners of $470 million).
Brookfield entered into a commitment agreement with the partnership in 2022 to subscribe for up to $1.5 billion of perpetual preferred equity securities of subsidiaries of the partnership (including subsidiaries of our company). As at March 31, 2025, the amount subscribed from our company was $nil (December 31, 2024: $nil) and the amount subscribed from other subsidiaries of Brookfield Business Partners was $725 million (December 31, 2024: $725 million) with an annual dividend of 7%. The remaining capacity available on the commitment agreement with Brookfield is $25 million. Brookfield will have the right to cause our company or Brookfield Business Partners to redeem the preferred securities at par to the extent of any net proceeds received by our company or Brookfield Business Partners from the issuance of equity, incurrence of indebtedness or sale of assets. Brookfield has the right to waive its redemption option.
Dividend Policy
The Board of Directors may declare dividends at its discretion. However, each exchangeable share has been structured with the intention of providing an economic return equivalent to one LP Unit. Our company targets to declare and pay dividends on the exchangeable shares at the same time as distributions are declared and paid on the LP Units and targets that dividends on each exchangeable share are declared and paid in the same amount as distributions are declared and paid on each LP Unit to provide holders of exchangeable shares with an economic return equivalent to holders of the LP Units.
The Board of Directors has declared a quarterly dividend in the amount of $0.0625 per exchangeable share, payable on June 30, 2025 to shareholders of record as at the close of business on May 30, 2025. This dividend is identical in amount per share and has identical record and payment dates to the quarterly distribution declared by the board of directors of the general partner of Brookfield Business Partners on its LP Units.
Cash Flow
We believe that we have sufficient access to capital resources and will continue to use our available capital resources to fund our operations. Our future capital resources include cash flow from operations, borrowings, proceeds from asset monetizations and proceeds from potential future equity issuances, if required.
As at March 31, 2025, we had cash and cash equivalents of $968 million, compared to $1,008 million as at December 31, 2024. The net cash flows for the three months ended March 31, 2025 and March 31, 2024, were as follows:
Three Months Ended
March 31,
(US$ MILLIONS) 2025 2024
Cash flow provided by (used in) operating activities $ (50) $ (53)
Cash flow provided by (used in) financing activities 71  124 
Cash flow provided by (used in) investing activities (90) (77)
Effect of foreign exchange rates on cash 29  (23)
Change in cash and cash equivalents $ (40) $ (29)
Cash flow provided by (used in) operating activities
Total cash flow used in operating activities for the three months ended March 31, 2025 was $50 million compared to cash flow used in operating activities of $53 million for the three months ended March 31, 2024. Cash flow used in operating activities during the three months ended March 31, 2025 was primarily attributable to timing of working capital changes within our construction operation. Net of non-cash working capital changes, cash flow provided by operating activities was $62 million for the three months ended March 31, 2025, primarily attributable to cash generated by our dealer software and technology services operation and water and wastewater operation.
10


Cash flow provided by (used in) financing activities
Total cash flow provided by financing activities was $71 million for the three months ended March 31, 2025, compared to cash flow provided by financing activities of $124 million for the three months ended March 31, 2024. During the three months ended March 31, 2025, our financing activities included proceeds from Brookfield Business Partners under the credit agreement as described in Note 20 of the unaudited interim condensed consolidated financial statements, combined with net proceeds from non-recourse borrowings, primarily related to our construction operation and our water and wastewater operation.
Cash flow provided by (used in) investing activities
Total cash flow used in investing activities was $90 million for the three months ended March 31, 2025, compared to cash flow used in investing activities of $77 million for the three months ended March 31, 2024. Cash flows used in investing activities were primarily related to capital expenditures of property, plant and equipment and intangible assets of $60 million, primarily at our water and wastewater operation and our healthcare services in Australia.
Off-Balance Sheet Arrangements
In the normal course of operations, our operating subsidiaries have bank guarantees, insurance bonds and letters of credit outstanding to third parties. As at March 31, 2025, the total outstanding amounts were approximately $1.5 billion. If these letters of credit or bonds are drawn upon, we will be obligated to reimburse the issuer of the letter of credit or bonds. Our company does not conduct its operations, other than those of equity accounted investments, through entities that are not consolidated in the consolidated financial statements and has not guaranteed or otherwise contractually committed to support any material financial obligations not reflected in the unaudited interim condensed consolidated financial statements.
BBUC Holdings Inc., a wholly owned subsidiary of our company, fully and unconditionally guaranteed (i) the obligations of Brookfield Business Partners under its $2.35 billion bilateral credit facilities and (ii) the obligations of Brookfield Business Partners under its $1 billion revolving acquisition credit facility with Brookfield. These arrangements do not have or are not reasonably likely to have a material current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.
Our construction operation and other operations may be called upon to give, in the ordinary course of business, guarantees and indemnities in respect of the performance of controlled entities, associates and related parties of their contractual obligations.
In the normal course of operations, our operating subsidiaries will execute agreements that provide for indemnification and guarantees to third parties in transactions such as business dispositions and acquisitions, construction projects, capital projects, and sales and purchases of assets and services. We have also agreed to indemnify our directors and certain of our officers and employees. The nature of substantially all of the indemnification undertakings prevents us from making a reasonable estimate of the maximum potential amount that we could be required to pay third parties, as many of the agreements do not specify a maximum amount and the amounts are dependent upon the outcome of future contingent events, the nature and likelihood of which cannot be determined at this time. Historically, we have made no significant payments under such indemnification agreements. In addition, we have also entered into indemnity agreements with Brookfield that relate to certain construction projects in the Middle East region that have been in place for several years. Under these indemnity agreements, Brookfield has agreed to indemnify us or refund us, as appropriate, for the receipt of payments relating to such projects.
From time to time, we may be contingently liable with respect to litigation and claims that arise in the normal course of operations. In our construction operation, this may include litigation and claims from clients or subcontractors, in addition to our associated counterclaims. Our dealer software and technology services operation has become subject to several class action lawsuits in connection with the cybersecurity incident in 2024 and the operation may be subject to further lawsuits, claims, inquiries or investigations. We believe that the legal proceedings are without merit and intend to vigorously contest them. On an ongoing basis, we assess the potential impact of these events. Aside from the costs to defend against these claims, the potential loss amount from these claims cannot be measured and is not probable at this time.
Contractual Obligations
An integral part of our company’s strategy is to participate with institutional partners in Brookfield-sponsored private equity funds that target acquisitions that suit Brookfield private equity’s profile. In the normal course of business, our company may make commitments to Brookfield-sponsored private equity funds to participate in these target acquisitions in the future, if and when identified.
11


In the ordinary course of business, we enter into contractual arrangements that may require future cash payments. The table below outlines our undiscounted contractual obligations as at March 31, 2025:
Payments as at March 31, 2025
(US$ MILLIONS) Total < 1 Year 1-2 Years 3-5 Years 5+ Years
Borrowings $ 8,972  $ 148  $ 210  $ 7,574  $ 1,040 
Lease liabilities 493  56  42  82  313 
Interest expense 6,575  789  759  1,823  3,204 
Obligations under agreements 10  10  —  —  — 
Exchangeable and class B shares 1,682  1,682  —  —  — 
Total $ 17,732  $ 2,685  $ 1,011  $ 9,479  $ 4,557 
Related Party Transactions
We entered into a number of related party transactions with Brookfield as described in Note 20 of the unaudited interim condensed consolidated financial statements.
Critical Accounting Policies, Estimates and Judgments
The preparation of financial statements requires management to make critical judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses that are not readily apparent from other sources, during the reporting period. These estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
For further reference on accounting policies, critical judgments and estimates, see our “Material Accounting Policy Information” contained in Note 2 of our annual consolidated financial statements as at December 31, 2024 and 2023 and for the years ended December 31, 2024, 2023 and 2022.
Global minimum top-up tax
The company operates in countries, including Canada, which have enacted new legislation to implement the global minimum top-up tax, effective from January 1, 2024. The company has applied a temporary mandatory relief from recognizing and disclosing deferred taxes in connection with the global minimum top-up tax and will account for it as a current tax when it is incurred. There is no material current tax impact for the three months ended March 31, 2025. The global minimum top-up tax is not anticipated to have a material impact on the financial position of the company.
Controls and procedures
No change in our internal control over financial reporting occurred during the three months ended March 31, 2025 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
12


Future changes in accounting policies
(i)Amendments to IFRS 9, Financial Instruments (“IFRS 9”) and IFRS 7, Financial Instruments: Disclosures (“IFRS 7”) - Classification and Measurement of Financial Instruments
In May 2024, the IASB issued amendments which clarify the requirements for the timing of recognition and derecognition of financial liabilities settled through an electronic cash transfer system, add further guidance for assessing the contractual cash flow characteristics of financial assets with contingent feature, and add new or amended disclosures relating to investments in equity instruments designated at FVOCI and financial instruments with contingent features. The amendments to IFRS 9 and IFRS 7 apply to annual reporting periods beginning on or after January 1, 2026, with early adoption permitted. The company is currently assessing the impact of these amendments.
(ii)IFRS 18, Presentation and Disclosure of Financial Statements (“IFRS 18”)
In April 2024, the IASB issued IFRS 18 to replace IAS 1 Presentation of Financial Statements (“IAS 1”). IFRS 18 is effective for periods beginning on or after January 1, 2027, with early adoption permitted. IFRS 18 aims to improve financial reporting by requiring additional defined subtotals in the statement of profit or loss, requiring disclosures about management-defined performance measures, and adding new principles for the aggregation and disaggregation of items. The company is currently assessing the impact of these amendments.
There are currently no other future changes to IFRS Accounting Standards with expected material impacts on the company.
13


Quick Links


14
EX-99.2 3 bbucq12025ex992.htm EX-99.2 Document

QuickLinks -- Click here to rapidly navigate through this document
Exhibit 99.2

FORM 52-109F2

CERTIFICATION OF INTERIM FILINGS — FULL CERTIFICATE

I, Anuj Ranjan, Chief Executive Officer of Brookfield Business Corporation, certify the following:
1.Review:    I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of Brookfield Business Corporation (the "issuer") for the interim period ended March 31, 2025.
2.No misrepresentations:    Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.
3.Fair presentation:    Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.
4.Responsibility:    The issuer's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers' Annual and Interim Filings, for the issuer.
5.Design:    Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer's other certifying officer(s) and I have, as at the end of the period covered by the interim filings
a.designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that
i.material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and
ii.information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and
b.designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer's GAAP.
5.1     Control framework:    The control framework the issuer's other certifying officer(s) and I used to design the issuer's ICFR is the Internal Control-Integrated Framework published by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
5.2     ICFR — material weakness relating to design:    N/A
5.3     Limitation on scope of design:    N/A



6.    Reporting changes in ICFR:    The issuer has disclosed in its interim MD&A any change in the issuer's ICFR that occurred during the period beginning on January 1, 2025 and ended on March 31, 2025 that has materially affected, or is reasonably likely to materially affect, the issuer's ICFR.


Date: May 6, 2025
/s/ Anuj Ranjan
Anuj Ranjan
Chief Executive Officer, Brookfield Business Corporation
   


EX-99.3 4 bbucq12025ex993.htm EX-99.3 Document

QuickLinks -- Click here to rapidly navigate through this document
Exhibit 99.3

FORM 52-109F2

CERTIFICATION OF INTERIM FILINGS — FULL CERTIFICATE

I, Jaspreet Dehl, Chief Financial Officer of Brookfield Business Corporation, certify the following:
1.Review:    I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of Brookfield Business Corporation (the "issuer") for the interim period ended March 31, 2025.
2.No misrepresentations:    Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.
3.Fair presentation:    Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.
4.Responsibility:    The issuer's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers' Annual and Interim Filings, for the issuer.
5.Design:    Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer's other certifying officer(s) and I have, as at the end of the period covered by the interim filings
a.designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that
i.material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and
ii.information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and
b.designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer's GAAP.
5.1     Control framework:    The control framework the issuer's other certifying officer(s) and I used to design the issuer's ICFR is the Internal Control-Integrated Framework published by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
5.2     ICFR — material weakness relating to design:    N/A
5.3     Limitation on scope of design:    N/A



6.    Reporting changes in ICFR:    The issuer has disclosed in its interim MD&A any change in the issuer's ICFR that occurred during the period beginning on January 1, 2025 and ended on March 31, 2025 that has materially affected, or is reasonably likely to materially affect, the issuer's ICFR.


Date: May 6, 2025
/s/ Jaspreet Dehl
Jaspreet Dehl
Chief Financial Officer, Brookfield Business Corporation